Speaker illustration

Doctor Dominick Joseph Angiolillo

University of Florida College of Medicine, Jacksonville (United States of America)

Member of:

European Society of Cardiology
EAPCI

Dominick Angiolillo is a Professor of Medicine, Director of Cardiovascular Research, Program Director of the Interventional Cardiology Fellowship Program at the University of Florida. Much of Dr. Angiolillo’s professional career has been devoted to cardiovascular research in the field of interventional cardiology and acute coronary syndrome. His largest national and international recognition has been for his pivotal contributions in the field of thrombosis. In particular, Dr. Angiolillo has performed seminal studies on platelet function and modulation of antiplatelet drug response, including genetic studies, for which he has received numerous national and international academic recognitions. He has also been a key investigator in the clinical development of numerous novel antithrombotic agents. Dr. Angiolillo has made major scientific contributions to many medical and cardiovascular journals, as well as textbooks.

NOACs in patients with atrial fibrillation: insights from the cardiac cath lab

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Stroke Prevention

Session type: Industry Q&A session

Thumbnail

NOACs in patients undergoing cardiac procedures

Event: ESC CONGRESS 2019

Topic: Atrial Fibrillation (AF)

Session type: Satellite Symposium

Thumbnail

Bleeding complications in ACS

Event: ESC Congress 2018

Topic: Epidemiology, Prognosis, Outcome

Session type: Abstract Sessions

Thumbnail

Residual cardiovascular risk after an acute coronary syndrome: identifying, stratifying and managing patients at long term risk of atherothrombotic cardiovascular events (EBAC Accredited)

Event: ESC Congress 2018

Topic: Coronary Artery Disease (Chronic) / Chronic Coronary Syndromes (CCS)

Session type: Satellite Symposium

Thumbnail

Residual cardiovascular risk after an acute coronary syndrome: identifying, stratifying and managing patients at long term risk of atherothrombotic cardiovascular events (EBAC Accredited)

Event: ESC Congress 2018

Topic: Coronary Artery Disease (Chronic) / Chronic Coronary Syndromes (CCS)

Session type: Satellite Symposium - Experts on the Spot

Thumbnail

Acute coronary syndromes in challenging situations

Event: ESC CONGRESS 2017

Topic: Infarction acute phase non STEMI

Session type: Meet the Experts

Thumbnail

Bridging of antithrombotic therapy for invasive procedure

Event: ESC CONGRESS 2016

Topic: Antithrombotic agents

Session type: Symposium

Thumbnail

This platform is supported by

logo Novo Nordisk